Antimicrobial Agents and Chemotherapy · 2002 · 127 citations · 5 references
Veterinary MedicinePharmacologyPharmacotherapyBiochemical PharmacologyChemotherapyEnzymologyEnzyme InhibitionParasitic Disease PathogenesisProtozoal InfectionsProtozoan Host-parasite InteractionsProtozoan ImmunologyProtozoan PathogenesisAntileishmanial TreatmentFarnesyl Diphosphate SynthaseIntravenous Chemotherapy AdministrationLeishmaniasis PathogenesisToxoplasmosis PathogenesisTreatment Of Leishmaniasis
The in vivo activities of three bisphosphonates were determined against Leishmania donovani and Toxoplasma gondii. Alendronate was essentially inactive against both parasites. Pamidronate was active against L. donovani by intravenous administration. Risedronate had a 50% effective dosage of five 2.6-mg/kg of body weight intraperitoneal doses against L. donovani-infected mice but was less effective against T. gondii-infected mice.
5
Simon L. Croft, Diane Snowdon, Vanessa Yardley · Journal of Antimicrobial Chemotherapy · 1996 · 182 citations · Full text
Julio A. Urbina, Benjamin Moreno, Stephanie Vierkotter et al. · Journal of Biological Chemistry · 1999 · 149 citations · Full text
A Peptide Prodrug Approach for Improving Bisphosphonate Oral Absorption
Aviva Ezra, Amnon Hoffman, Eli Breuer et al. · Journal of Medicinal Chemistry · 2000 · 103 citations
Fausto G. Araujo, Anis A. Khan, TeriR. Slifer et al. · Antimicrobial Agents and Chemotherapy · 1997 · 40 citations · Full text